Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

ClinicalTrials.gov ID: NCT07287670

Public ClinicalTrials.gov record NCT07287670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 6:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-Controlled Study to Assess the Safety and Efficacy of MTX-474 in the Treatment of Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Study identification

NCT ID
NCT07287670
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mediar Therapeutics
Industry
Enrollment
85 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 15, 2026
Primary completion
Nov 30, 2028
Completion
Nov 30, 2028
Last update posted
Aug 4, 2026

2026 – 2028

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
EncompaSSc site in Phoenix, AZ Phoenix Arizona 85054 Not yet recruiting
EncompaSSc site in La Jolla, CA La Jolla California 92037 Not yet recruiting
EncompaSSc site in Loma Linda, CA Loma Linda California 92350 Not yet recruiting
University of California Los Angeles Scleroderma Center Los Angeles California 90095 Recruiting
NewportNativeMD, Inc. Newport Beach California 92663 Recruiting
EncompaSSc site in Palo Alto, CA Palo Alto California 94304 Not yet recruiting
University of Colorado Center for Lungs/Breathing/Scleroderma Clinic Aurora Colorado 80045 Recruiting
Clinical Research of West Florida Clearwater Florida 33765 Recruiting
EncompaSSc site in Sarasota, FL Sarasota Florida 34239 Not yet recruiting
Clinical Research of West Florida Tampa Florida 33606 Recruiting
EncompaSSc site in Kansas City, KS Kansas City Kansas 66103 Not yet recruiting
Johns Hopkins University Baltimore Maryland 21205 Recruiting
Brigham and Women's Hospital Boston Massachusetts 02115 Recruiting
Boston Medical Center Boston Massachusetts 02118 Recruiting
EncompaSSc site in Minneapolis, MN Minneapolis Minnesota 55455 Not yet recruiting
EncompaSSc site in Brooklyn, NY Brooklyn New York 11201 Not yet recruiting
EncompaSSc site in Cleveland, OH Cleveland Ohio 44195 Not yet recruiting
EncompaSSc site in Oklahoma City, OK Oklahoma City Oklahoma 73104 Not yet recruiting
EncompaSSc site in Philadelphia, PA Philadelphia Pennsylvania 19107 Not yet recruiting
EncompaSSc site in Pittsburgh, PA Pittsburgh Pennsylvania 15219 Not yet recruiting
Stryde Research - DFW Allen Texas 75013 Recruiting
Baylor Scott & White Research Institute Dallas Texas 75246 Recruiting
EncompaSSc site in Houston, TX Houston Texas 77030 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07287670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07287670 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →